Navigation Links
InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
Date:11/6/2008

by dialing 888-799-0528 (U.S.) or 706-634-0154 (international), conference ID# 71184785. A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at http://www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 71184785. The webcast will remain available on the company's website until the next earnings call.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...cative new study, a University of Utah scientist a...jor cause of global warming cannot be stabilized ...ilds the equivalent of one new nuclear power plant... be any substantial near-term departure from recen...on rates," says the new paper by Tim Garrett, an a...
(Date:11/23/2009)...unication, computation and more powerful ways to e...antum states as carriers of information is an extr...hown, mathematically, how to gently tease out unwa... the information intact. Their work is reported in...d highlighted with a Viewpoint in Physics ( http...
(Date:11/23/2009)...e-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI ...2009astheex-dividenddateforits$200millionspecialdi...transactioncompletedonNovember2,2009.Thedividendwi...ontherecorddate,December1,2009.NASDAQhassettheappr...fcommonstockforpurposesoftheex-dividenddateonNovem...
(Date:11/23/2009)...tCall/--NeogenCorporation(Nasdaq: NEOG )announcedt...sBoardofDirectorsatthecompany,srecentannualmeeting...xperienceinthefood,agriculture,andtradeindustriesa...leconomicsatVirginiaTechUniversity.FromJanuary2006...enegotiatorwiththerankofambassador. ,, "Sinceou...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2
...iences,Holdings, Inc. (Nasdaq: ADLS ), today anno... U.S. Food and Drug Administration (FDA), the Comp...n the third quarter of 2008 for its,novel once-a-d...moderate,community acquired pneumonia (CAP)., (Lo...ALSLOGO ), "We are pleased with the outcome of th...
...s with systemic lupus erythematosus and lupus-...io of antiphospholipid produ...on,(OTC Bulletin Board: CONX) announced receipt of...ug Administration (FDA) for the Company,s IgG,Anti...w available,worldwide, utilizes the Company,s pate...
...dside bombs may become easier, thanks to chemical ...gan. , A team led by chemistry professor Theodore...TNT and give off signals that can be detected remo...rk was recently described in the journal Nanotechn... the 235th national meeting of the American Chemic...
Other Biology Technology:Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 2Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 3Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit 2Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit 3Safer, easier system for remote explosive detection 2
(Date:11/23/2009)...ber 16, 2009 -- A USDOE and USDA study concluded t...nd, and cropland pasture could be converted from c..., such as switchgrass, from which biomass could be...cally viable production of a perennial grass monoc...s are removed annually is expected to require nitr...
(Date:11/23/2009)...uthern California biomedical engineer and cardiolo...l to help clinicians distinguish cardiac emergenci...ms manageable with drugs and lifestyle change. , ...o the arteries feeding the heart, offer an inside ...ood vessels, often revealing deposits of a dangero...
(Date:11/23/2009)...tute of General Medical Sciences (NIGMS), part of ...ing $42.3 million for grants in scientific areas i...veloped the GO grant program to stimulate biomedic...y the American Recovery and Reinvestment Act (Reco...romise to have a significant impact on a field of ...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 1ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 4US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 1US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 2US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 3
...searchers, in collaboration with the International...ydney University, the research illustrates the maj...odification (GM) technology. , Wheat breeders oft... genes in breeding new disease-resistant wheats, r...unately genes from wild relatives usually come in ...
...rvation satellites in combating climate change is ...ange conference where thousands of delegates from ...tiations of an international emissions-cutting agr...commitment period ends in 2012. , The Protocol co...se gases chief among them carbon dioxide believe...
...ncient fish bones in Scandinavia have discovered t...a bream that ,once thrived in Danish waters during... cold-water species, such as cod, were also abunda...wer fishing effort. , Through the study of archae...and account books of monasteries, an international...
Other Biology News:Building disease-beating wheat 2UN climate conference hears how EO can help 2UN climate conference hears how EO can help 3Ancient fish bones reveal impacts of global warming beneath the sea 2Ancient fish bones reveal impacts of global warming beneath the sea 3Ancient fish bones reveal impacts of global warming beneath the sea 4Ancient fish bones reveal impacts of global warming beneath the sea 5
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Mouse sRANKL Antibody, Biotin Conjugated from Cell Sciences
Anti-TIMP-4 (Tissue Inhibitor of Metalloproteinases-4), Loop #3 Polyclonal Antibody, Unconjugated from CHEMICON
Rabbit Anti-Oct2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: